Clinical Trial Update: Immunogenicity of Different Primary Immunization Schedules with Inactivated Poliovirus Vaccine (IPV) Plus Pentavalent Vaccine (DTwP-HBV-Hib) or with Hexavalent Vaccine (DTwP-HBV-Hib-IPV) [Phase 4]

View source ↗

Summary

This ClinicalTrials.gov entry outlines a Phase 4 study evaluating the immunogenicity of different primary immunization schedules using inactivated poliovirus va…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Poliomyelitis

Drugs mentioned

• Hexavalent vaccine (DTwP-HBV-Hib-IPV) (Diphtheria, Tetanus, Pertussis, Hepatitis B, Haemophilus influenzae type b, Poliovirus vaccine)
• Inactivated Poliovirus Vaccine (IPV) (Inactivated Poliovirus Vaccine)
• Pentavalent vaccine (DTwP-HBV-Hib) (Diphtheria, Tetanus, Pertussis, Hepatitis B, Haemophilus influenzae type b vaccine)

Snippet

Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh | Conditions: Polio | Phase 4 | Status: NOT_YET_RECRUITING